Latest Articles
Brian Slomovitz on Adjuvant Pembrolizumab/Chemotherapy for Advanced Endometrial Cancer - Medpage Today
Brian Slomovitz on Adjuvant Pembrolizumab/Chemotherapy for Advanced Endometrial Cancer Medpage Today
Published: Dec. 18, 2024, 3:27 p.m.
GSK’s Jemperli receives positive CHMP opinion for expanded endometrial cancer use - PMLiVE
GSK’s Jemperli receives positive CHMP opinion for expanded endometrial cancer use PMLiVE
Published: Dec. 18, 2024, 12:25 p.m.
Molecular Classification Drives Advances in Endometrial Cancer Treatment - Journal of Clinical Pathways
Molecular Classification Drives Advances in Endometrial Cancer Treatment Journal of Clinical Pathways
Published: Dec. 17, 2024, 3:25 p.m.
GSK's Jemperli receives positive CHMP opinion for endometrial cancer - Investing.com India
GSK's Jemperli receives positive CHMP opinion for endometrial cancer Investing.com India
Published: Dec. 16, 2024, 7:47 p.m.
GSK's Jemperli receives positive CHMP opinion for endometrial cancer - Investing.com
GSK's Jemperli receives positive CHMP opinion for endometrial cancer Investing.com
Published: Dec. 16, 2024, 5:30 p.m.
Different surgical methods of hysterectomy for the management of endometrial cancer: A systematic review and network meta-analysis - Frontiers
Different surgical methods of hysterectomy for the management of endometrial cancer: A systematic review and network meta-analysis Frontiers
Published: Dec. 16, 2024, 4:23 p.m.
Dostarlimab Plus Chemo Earns Positive CHMP Opinion for Expanded Indication in Advanced Endometrial Cancer - OncLive
Dostarlimab Plus Chemo Earns Positive CHMP Opinion for Expanded Indication in Advanced Endometrial Cancer OncLive
Published: Dec. 16, 2024, 4:21 p.m.
GSK’s Jemperli Set for Expanded EMA Approval for Endometrial Cancer - TipRanks
GSK’s Jemperli Set for Expanded EMA Approval for Endometrial Cancer TipRanks
Published: Dec. 16, 2024, 7:45 a.m.
EU recommends expanding use of GSK endometrial cancer drug - ShareCast
EU recommends expanding use of GSK endometrial cancer drug ShareCast
Published: Dec. 16, 2024, 7:35 a.m.
Acrivon Therapeutics: Endometrial Cancer Data Continues To Justify A Nascent Thesis - Seeking Alpha
Acrivon Therapeutics: Endometrial Cancer Data Continues To Justify A Nascent Thesis Seeking Alpha
Published: Dec. 12, 2024, 8:25 p.m.
Link copied to clipboard!